Biogen (BIIB) News Today $140.55 -0.68 (-0.48%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Guardian Investment Management Sells 2,865 Shares of Biogen Inc. (NASDAQ:BIIB)Guardian Investment Management trimmed its stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 28.2% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 7,300 shares of the biotechnology company's stock after selling 2,865 shares durJanuary 20 at 6:21 AM | marketbeat.comSax Wealth Advisors LLC Invests $337,000 in Biogen Inc. (NASDAQ:BIIB)Sax Wealth Advisors LLC purchased a new stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 2,203 shares of the biotechnology company's stock, valued at approximatelJanuary 19 at 4:49 AM | marketbeat.comAvanza Fonder AB Buys Shares of 15,536 Biogen Inc. (NASDAQ:BIIB)Avanza Fonder AB purchased a new position in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 15,536 shares of the biotechnology company's stock, valued at apprJanuary 19 at 4:18 AM | marketbeat.comWedge Capital Management L L P NC Acquires 26,530 Shares of Biogen Inc. (NASDAQ:BIIB)Wedge Capital Management L L P NC raised its holdings in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 17.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 179,191 shares of the biotechnology company's stock afJanuary 18 at 6:11 AM | marketbeat.comSage sues Biogen in wake of $469M buyout offer: reportJanuary 18 at 1:59 AM | seekingalpha.comBiogen's Quarterly Earnings Preview: What You Need to KnowJanuary 17 at 11:03 PM | msn.comRDA Financial Network Makes New Investment in Biogen Inc. (NASDAQ:BIIB)RDA Financial Network acquired a new stake in Biogen Inc. (NASDAQ:BIIB - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 3,210 shares of the biotechnology company's stock, valued at approximately $491,000. A number of oJanuary 17 at 8:50 AM | marketbeat.comBiogen (NASDAQ:BIIB) Sets New 52-Week Low - Here's What HappenedBiogen (NASDAQ:BIIB) Hits New 1-Year Low - Here's WhyJanuary 16, 2025 | marketbeat.comBiogen Hold Rating: Balancing Promising Prospects with Market UncertaintiesJanuary 16, 2025 | markets.businessinsider.comWedmont Private Capital Boosts Position in Biogen Inc. (NASDAQ:BIIB)Wedmont Private Capital boosted its position in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 187.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,670 shares of the biotechnology company's stock after acquiringJanuary 16, 2025 | marketbeat.comCzech National Bank Has $4.83 Million Stock Holdings in Biogen Inc. (NASDAQ:BIIB)Czech National Bank boosted its position in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 6.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 31,595 shares of the biotechnology company's stock after acquiringJanuary 16, 2025 | marketbeat.comShort Interest in Biogen Inc. (NASDAQ:BIIB) Increases By 42.6%Biogen Inc. (NASDAQ:BIIB - Get Free Report) saw a large increase in short interest in the month of December. As of December 31st, there was short interest totalling 3,680,000 shares, an increase of 42.6% from the December 15th total of 2,580,000 shares. Currently, 2.5% of the shares of the company are sold short. Based on an average daily volume of 1,490,000 shares, the days-to-cover ratio is presently 2.5 days.January 15, 2025 | marketbeat.comBiogen’s Hold Rating: Navigating Challenges in Alzheimer’s Treatments and Pipeline DevelopmentJanuary 15, 2025 | markets.businessinsider.comSage Therapeutics: Biogen's Unsolicited Bid Is Best Step Forward For ShareholdersJanuary 15, 2025 | seekingalpha.comBiogen Inc. (BIIB) J.P. Morgan 43rd Annual Healthcare Conference (Transcript)January 15, 2025 | seekingalpha.comBiogen Announces New Chief Accounting Officer AppointmentJanuary 15, 2025 | tipranks.comBiogen lays out three FDA decisions that could ramp up Alzheimers drug launchJanuary 15, 2025 | bizjournals.comWilliam Blair Reaffirms Outperform Rating for Biogen (NASDAQ:BIIB)January 15, 2025 | americanbankingnews.comSarepta, Biogen drugs with accelerated approval under fire in FDA reportJanuary 14, 2025 | msn.comBiogen CEO sees no burning need for more acquisitionsJanuary 14, 2025 | reuters.comBiogen Inc. stock underperforms Monday when compared to competitors despite daily gainsJanuary 14, 2025 | marketwatch.comBiogen (NASDAQ:BIIB) Reaches New 12-Month Low - Here's What HappenedBiogen (NASDAQ:BIIB) Reaches New 52-Week Low - Here's WhyJanuary 14, 2025 | marketbeat.comFDA To Review Under the Skin Weekly Autoinjector For Biogen/Eisai's Alzheimer's Drug LeqembiJanuary 14, 2025 | benzinga.comBiogen, Eisai say injectable Alzheimer’s therapy granted FDA reviewJanuary 14, 2025 | seekingalpha.comBiogen Insider Ups Holding During YearJanuary 14, 2025 | finance.yahoo.comTruist Financial Remains a Buy on Biogen (BIIB)January 14, 2025 | markets.businessinsider.comFDA accepts Eisai/Biogen’s BLA for LEQEMBI in early AD treatmentJanuary 14, 2025 | msn.comPiper Sandler Sticks to Its Hold Rating for Biogen (BIIB)January 14, 2025 | markets.businessinsider.comEisai and Biogen Announce FDA Acceptance of Lecanemab Subcutaneous Autoinjector Application for Alzheimer's Disease TreatmentJanuary 13, 2025 | quiverquant.comFDA Accepts LEQEMBI® (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's DiseaseJanuary 13, 2025 | globenewswire.comBiogen's (BIIB) "Outperform" Rating Reaffirmed at William BlairWilliam Blair restated an "outperform" rating on shares of Biogen in a research note on Monday.January 13, 2025 | marketbeat.comBiogen Bid For Sage Therapeutics Could Strengthen Neurology Strategy: AnalystsJanuary 13, 2025 | benzinga.comSage Therapeutics shares surge on unsolicited takeover bid from BiogenJanuary 13, 2025 | proactiveinvestors.comWhy Is Depression-Focused Sage Therapeutics Stock Surging Higher On Monday?January 13, 2025 | benzinga.comSage Therapeutics shares spike after Biogen offers to buy remaining stakeJanuary 13, 2025 | investing.comWhy Is Depression-Focused Sage Therapeutics Stock Surging Higher On Monday?January 13, 2025 | finance.yahoo.comSage Therapeutics Stock Soars as Biogen Makes Unsolicited Takeover BidJanuary 13, 2025 | msn.comSage Therapeutics Stock Rockets 35% Higher After Takeover Bid From BiogenJanuary 13, 2025 | barrons.comWells Fargo & Company Lowers Biogen (NASDAQ:BIIB) Price Target to $165.00January 13, 2025 | americanbankingnews.comSage confirms Biogen’s bid to acquire remaining stakeJanuary 12, 2025 | seekingalpha.comCan 2025 J.P. Morgan Healthcare Conference spark biotech M&A?January 11, 2025 | msn.comSage confirms Biogen’s bid to acquire remaining stakeJanuary 11, 2025 | msn.comTruist Financial Cuts Biogen (NASDAQ:BIIB) Price Target to $220.00January 11, 2025 | americanbankingnews.comBiogen offers to buy out Sage TherapeuticsJanuary 11, 2025 | bizjournals.comSage Therapeutics confirms $7.22 per share acquisition proposal from BiogenJanuary 11, 2025 | msn.comDeal Or No Deal? Sage Therapeutics Soars On Acquisition Proposal From Biogen January 10, 2025 | rttnews.comSage Therapeutics Confirms Receipt of Unsolicited Nonbinding Acquisition Proposal from BiogenJanuary 10, 2025 | businesswire.comBiogen proposes to buy remaining stake in Sage in $442 million dealJanuary 10, 2025 | reuters.comWells Fargo Issues a Hold Rating on Biogen (BIIB)January 10, 2025 | markets.businessinsider.comWells Fargo & Company Cuts Biogen (NASDAQ:BIIB) Price Target to $165.00Wells Fargo & Company reduced their price target on shares of Biogen from $190.00 to $165.00 and set an "equal weight" rating on the stock in a research report on Friday.January 10, 2025 | marketbeat.com Get Biogen News Delivered to You Automatically Sign up to receive the latest news and ratings for BIIB and its competitors with MarketBeat's FREE daily newsletter. Email Address BIIB Media Mentions By Week BIIB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIIB News Sentiment▼0.540.44▲Average Medical News Sentiment BIIB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIIB Articles This Week▼3221▲BIIB Articles Average Week Get Biogen News Delivered to You Automatically Sign up to receive the latest news and ratings for BIIB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Regeneron Pharmaceuticals News Today Alnylam Pharmaceuticals News Today United Therapeutics News Today Neurocrine Biosciences News Today Incyte News Today BioMarin Pharmaceutical News Today Exelixis News Today Exact Sciences News Today Repligen News Today Halozyme Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BIIB) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s Inauguration Shocker: “Move Your Cash Now”Just in the first week after Trump's win, many stocks jumped by double and even triple digits. But now he's...InvestorPlace | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biogen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
